Iannazzo, S. et al. 2016. [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]. Farmeconomia. Health economics and therapeutic pathways. 17, 1 (Mar. 2016), 19–27. DOI:https://doi.org/10.7175/fe.v17i1.1238.